Alpha 1 antichymotrypsin is aberrantly expressed during melanoma progression and predicts poor survival for patients with metastatic melanoma.
Wang
Yang
Y
Jiang
Helen
H
Dai
Derek
D
Su
Mingwan
M
Martinka
Magdalene
M
Brasher
Penny
P
Zhang
Yaohua
Y
McLean
David
D
Zhang
Junling
J
Ip
Wency
W
Li
Gang
G
Zhang
Xuejun
X
Zhou
Youwen
Y
D014408:Biomarkers, Tumor / Q000096:biosynthesis* / Q000378:metabolism; D018450:Disease Progression; D015972:Gene Expression Regulation, Neoplastic / Q000235:genetics*; D006801:Humans; D008545:Melanoma / Q000175:diagnosis* / Q000378:metabolism* / Q000473:pathology; D009362:Neoplasm Metastasis; D009367:Neoplasm Staging; D011379:Prognosis; D016019:Survival Analysis; D000514:alpha 1-Antichymotrypsin / Q000096:biosynthesis* / Q000378:metabolism
D014408:Biomarkers, Tumor; D000514:alpha 1-Antichymotrypsin